Mentions
Extended reach
Total likes
Video views
AI synopsis
Several discussions highlight the significance of the TARGET study by emphasizing that a patient-driven webtool offers a valuable alternative to traditional genetic counseling, with words like 'useful' and 'access' reflecting perceived practical benefits. The tone indicates an appreciation for innovative approaches in genetic education, which suggests a positive outlook on its potential influence on healthcare practices.
Most discussions express support for the research or acknowledge its usefulness, indicating general agreement.
The topic of digital genetic education and prostate cancer screening attracts high interest, as shown by enthusiasm and keywords like 'useful' and 'access.'
Participants engage by referencing the study's methods and implications, suggesting they are processing the information more deeply.
The discussions recognize the potential importance of digital tools in healthcare access, implying a moderate but meaningful impact.
Read about TARGET, a randomized non-inferiority trial to compare pretest genetic education via a webtool for noninferiority to traditional genetic counseling (GC) in patients with #ProstateCancer (PCA). ➡️ https://t.co/X4eXasNFX7 @LoebStacy @vedangiri #pcsm https://t.co/yJ7iVIahA2
TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline Testing | JCO Precision Oncology https://t.co/wHvoGPkUcB
RT @JCOPO_ASCO: Read about TARGET, a randomized non-inferiority trial to compare pretest genetic education via a webtool for noninferiority…
The #TARGET study from @vedangiri and colleagues shows a patient-driven digital webtool for ⬆️access to pretest education for #genetictesting in patients with #prostatecancer is a useful format to deliver patient information. @SmilowCancer @YaleMed @YNHH https://t.co/ftF7fBVyK8
This episode summarizes the TARGET trial, a study comparing a patient-driven webtool and traditional genetic counseling for prostate cancer genetic testing. Both methods effectively reduce decisional conflict and…
RT @JCOPO_ASCO: Read about TARGET, a randomized non-inferiority trial to compare pretest genetic education via a webtool for noninferiority…
Read about TARGET, a randomized non-inferiority trial to compare pretest genetic education via a webtool for noninferiority to traditional genetic counseling (GC) in patients with #ProstateCancer (PCA). ➡️ https://t.co/X4eXasNFX7 @LoebStacy @vedangiri #pcsm https://t.co/yJ7iVIahA2
The #TARGET study from @vedangiri and colleagues shows a patient-driven digital webtool for ⬆️access to pretest education for #genetictesting in patients with #prostatecancer is a useful format to deliver patient information. @SmilowCancer @YaleMed @YNHH https://t.co/ftF7fBVyK8
TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline Testing | JCO Precision Oncology https://t.co/wHvoGPkUcB